Skip to main content
. 2003 Nov 25;89(11):2023–2026. doi: 10.1038/sj.bjc.6601446

Table 1. Characteristics of 170 endometrial cancer patients according to stage.

  Stage I (n=112) n (%) Stage II (n=14) n (%) Stage IIIA cyt (n=17) n (%) Stage IIIA hist (n=18) n (%) Stage IIIB+(n=9) n (%)
Mean age (range) years 64 (33–81) 66 (55–78) 66 (51–81) 65 (42–90) 65 (37–77)
           
Age category (years)
 <50 7 (6) 2 (11) 1 (11)
 50–69 71 (63) 10 (71) 12 (71) 10 (56) 4 (44)
 70+ 34 (31) 4 (29) 5 (29) 6 (33) 4 (44)
           
Period of diagnosis
 1980–1987 65 (58) 4 (29) 5 (29) 5 (28) 7 (78)
 1988–1993 47 (42) 10 (71) 12 (71) 13 (72) 2 (22)
           
Invasion of myometrium
 <50% 70 (63) 4 (29) 8 (47) 5 (28) 4 (44)
 ⩾50% 42 (37) 10 (71) 9 (53) 13 (72) 5 (56)
           
Differentiation
 Good 67 (60) 5 (45) 8 (57) 6 (38) 2 (22)
 Moderate 30 (27) 4 (36) 3 (21) 4 (25) 4 (44)
 Poor 15 (13) 2 (18) 3 (21) 6 (38) 3 (33)
 Unknown 3 3 2
           
Surgical treatment
 Hysterectomy 3 (3)
 Hysterectomy+unilat/Bilateral annexectomy Idem plus lymphadenectomy 105 (94) 13 (93) 16 (94) 17 (94) 4 (44)
  4 (3) 1 (7) 1 (6) 1 (6) 5 (56)
           
Radiotherapy
 External and brachy 46 (42) 11 (92) 11 (58) 15 (83) 7 (78)
 External only 8 (7) 3 (21) 3 (17) 2 (22)
 Brachy only 56 (51) 1 (8) 3 (21)
 Unknown 2 2

Stage I=tumour confined to uterus; stage II=tumour invading cervix; stage IIIA cyt=positive peritoneal cytology; stage IIIA hist=histological involvement of serosa or adnexa; stage IIIB+=tumour invading vagina, mucosa of bladder/bowel, regional lymph node or distant metastases.